EGFR-V834L combined with L858R mutation reduced afatinib sensitivity and associated to early recurrence in lung cancer

Nanao Terada(Kanazawa University), Seiji Yano(Life Science Institute)
Translational Lung Cancer Research
November 1, 2024
Cited by 1


Related Papers

No related papers found

Powered by citation graph analysis